{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:09:59Z","timestamp":1793639399145,"version":"4.5.1"},"reference-count":58,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"the Soci\u00e9t\u00e9 National Fran\u00e7aise de M\u00e9decine Interne"},{"name":"The Fondation pour la Recherche M\u00e9dical"},{"name":"Assistance Publique-H\u00f4pitaux de Paris"},{"name":"the French Arthritis Foundation"},{"DOI":"10.13039\/501100005737","name":"Universit\u00e9 Pierre-et-Marie-Curie (UPMC) Paris 6","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005737","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale"}],"content-domain":{"domain":["acrjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Arthritis &amp; Rheumatology"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      No simple or standardized assay is available to quantify interferon\u2010\u03b1 (\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      \u03b1) in routine clinical practice. Single\u2010molecule array (Simoa) digital enzyme\u2010linked immunosorbent assay (\n                      <jats:styled-content style=\"fixed-case\">ELISA<\/jats:styled-content>\n                      ) technology enables direct\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      \u03b1 quantification at attomolar (femtogram per milliliter [fg\/ml]) concentrations. This study was undertaken to assess\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      \u03b1 digital\n                      <jats:styled-content style=\"fixed-case\">ELISA<\/jats:styled-content>\n                      diagnostic performances to monitor systemic lupus erythematosus (\n                      <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>\n                      ) activity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      \u03b1 concentrations in serum samples from 150 consecutive\n                      <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>\n                      patients in a cross\u2010sectional study were determined with digital\n                      <jats:styled-content style=\"fixed-case\">ELISA<\/jats:styled-content>\n                      and a functional biologic activity assay (bioassay). According to their Safety of Estrogens in Lupus Erythematosus National Assessment version of the Systemic Lupus Erythematosus Disease Activity Index (\n                      <jats:styled-content style=\"fixed-case\">SLEDAI<\/jats:styled-content>\n                      ) flare composite scores, patients were divided into groups with inactive\n                      <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">SLEDAI<\/jats:styled-content>\n                      score of &lt;4 or clinical\n                      <jats:styled-content style=\"fixed-case\">SLEDAI<\/jats:styled-content>\n                      score of 0) or active\n                      <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">SLEDAI<\/jats:styled-content>\n                      score of \u22654 or clinical\n                      <jats:styled-content style=\"fixed-case\">SLEDAI<\/jats:styled-content>\n                      score of &gt;0), and into groups with no flare or mild\/moderate flare or severe flare.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Based on serum samples from healthy blood donors, the abnormal serum\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      \u03b1 level threshold value was 136 fg\/ml. Next, using receiver operating characteristic curves for an\n                      <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>\n                      patient series that was widely heterogeneous in terms of disease activity and organ involvement, the threshold\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      \u03b1 value associated with active disease was determined to be 266 fg\/ml. The digital\n                      <jats:styled-content style=\"fixed-case\">ELISA<\/jats:styled-content>\n                      \u2013assessed serum\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      \u03b1 level was a better biomarker of disease activity than the Farr assay because its specificity, likelihood ratio for positive results, and positive predictive value better discerned active\n                      <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>\n                      or flare from inactive disease. The digital\n                      <jats:styled-content style=\"fixed-case\">ELISA<\/jats:styled-content>\n                      was more sensitive than the bioassay for detecting low\u2010abnormal serum\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      \u03b1 concentrations and identifying patients with low disease activity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Direct serum\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      \u03b1 determination with a highly sensitive assay might improve monitoring of clinical\n                      <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>\n                      activity and selection of the best candidates for anti\u2010\n                      <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\n                      \u03b1 treatment.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/art.40792","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T06:04:40Z","timestamp":1543817080000},"page":"756-765","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Monitoring Disease Activity in Systemic Lupus Erythematosus With Single\u2010Molecule Array Digital Enzyme\u2010Linked Immunosorbent Assay Quantification of Serum Interferon\u2010\u03b1"],"prefix":"10.1002","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7653-6528","authenticated-orcid":false,"given":"Alexis","family":"Mathian","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9 Assistance Publique\u2013H\u00f4pitaux de Paris Groupement Hospitalier Piti\u00e9\u2013Salp\u00eatri\u00e8re French National Referral Center for Systemic Lupus Erythematosus Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders Service de M\u00e9decine Interne 2 Institut E3M, Inserm UMRS Centre d\u2019Immunologie et des Maladies Infectieuses (CIMI\u2010Paris)  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Mouries\u2010Martin","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Dijon H\u00f4pital Fran\u00e7ois\u2010Mitterrand Service de m\u00e9decine interne et maladies syst\u00e9miques (m\u00e9decine interne 2)  Dijon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9539-3203","authenticated-orcid":false,"given":"Karim","family":"Dorgham","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9 Inserm UMRS Centre d\u2019Immunologie et des Maladies Infectieuses (CIMI\u2010Paris) Assistance Publique\u2013H\u00f4pitaux de Paris Groupement Hospitalier Piti\u00e9\u2013Salp\u00eatri\u00e8re  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Devilliers","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Dijon H\u00f4pital Fran\u00e7ois\u2010Mitterrand Service de m\u00e9decine interne et maladies syst\u00e9miques (m\u00e9decine interne 2) and Centre d\u2019Investigation Clinique Inserm CIC 1432  Dijon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Barnabei","sequence":"additional","affiliation":[{"name":"Laboratory of Immunogenetics of Pediatric Autoimmune Diseases INSERM UMR\u2010Institut Imagine Sorbonne Paris Cit\u00e9  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ely\u00e8s","family":"Ben Salah","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9 Inserm UMRS Centre d\u2019Immunologie et des Maladies Infectieuses (CIMI\u2010Paris) Assistance Publique\u2013H\u00f4pitaux de Paris Groupement Hospitalier Piti\u00e9\u2013Salp\u00eatri\u00e8re  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7610-4995","authenticated-orcid":false,"given":"Fleur","family":"Cohen\u2010Aubart","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9 Assistance Publique\u2013H\u00f4pitaux de Paris Groupement Hospitalier Piti\u00e9\u2013Salp\u00eatri\u00e8re French National Referral Center for Systemic Lupus Erythematosus Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders Service de M\u00e9decine Interne 2 Institut E3M, Inserm UMRS Centre d\u2019Immunologie et des Maladies Infectieuses (CIMI\u2010Paris)  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Garrido Castillo","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9 Inserm UMRS Centre d\u2019Immunologie et des Maladies Infectieuses (CIMI\u2010Paris) Assistance Publique\u2013H\u00f4pitaux de Paris Groupement Hospitalier Piti\u00e9\u2013Salp\u00eatri\u00e8re  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Haroche","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9 Assistance Publique\u2013H\u00f4pitaux de Paris Groupement Hospitalier Piti\u00e9\u2013Salp\u00eatri\u00e8re French National Referral Center for Systemic Lupus Erythematosus Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders Service de M\u00e9decine Interne 2 Institut E3M, Inserm UMRS Centre d\u2019Immunologie et des Maladies Infectieuses (CIMI\u2010Paris)  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Hie","sequence":"additional","affiliation":[{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris Groupement Hospitalier Piti\u00e9\u2013Salp\u00eatri\u00e8re French National Referral Center for Systemic Lupus Erythematosus Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders Service de M\u00e9decine Interne 2 Institut E3M  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pineton de Chambrun","sequence":"additional","affiliation":[{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris Groupement Hospitalier Piti\u00e9\u2013Salp\u00eatri\u00e8re French National Referral Center for Systemic Lupus Erythematosus Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders Service de M\u00e9decine Interne 2 Institut E3M  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Miyara","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9 Inserm UMRS Centre d\u2019Immunologie et des Maladies Infectieuses (CIMI\u2010Paris) Assistance Publique\u2013H\u00f4pitaux de Paris Groupement Hospitalier Piti\u00e9\u2013Salp\u00eatri\u00e8re  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Sterlin","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9 Inserm UMRS Centre d\u2019Immunologie et des Maladies Infectieuses (CIMI\u2010Paris) Assistance Publique\u2013H\u00f4pitaux de Paris Groupement Hospitalier Piti\u00e9\u2013Salp\u00eatri\u00e8re  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheline","family":"Pha","sequence":"additional","affiliation":[{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris Groupement Hospitalier Piti\u00e9\u2013Salp\u00eatri\u00e8re French National Referral Center for Systemic Lupus Erythematosus Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders Service de M\u00e9decine Interne 2 Institut E3M  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du","family":"L\u00ea Thi Huong","sequence":"additional","affiliation":[{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris Groupement Hospitalier Piti\u00e9\u2013Salp\u00eatri\u00e8re French National Referral Center for Systemic Lupus Erythematosus Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders Service de M\u00e9decine Interne 2 Institut E3M  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Rieux\u2010Laucat","sequence":"additional","affiliation":[{"name":"Laboratory of Immunogenetics of Pediatric Autoimmune Diseases INSERM UMR\u2010Institut Imagine Sorbonne Paris Cit\u00e9  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flore","family":"Rozenberg","sequence":"additional","affiliation":[{"name":"Sorbonne Paris Cit\u00e9 Assistance Publique\u2013H\u00f4pitaux de Paris H\u00f4pital Cochin Service de Virologie  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2097-9677","authenticated-orcid":false,"given":"Guy","family":"Gorochov","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9 Inserm UMRS Centre d\u2019Immunologie et des Maladies Infectieuses (CIMI\u2010Paris) Assistance Publique\u2013H\u00f4pitaux de Paris Groupement Hospitalier Piti\u00e9\u2013Salp\u00eatri\u00e8re  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahir","family":"Amoura","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9 Assistance Publique\u2013H\u00f4pitaux de Paris Groupement Hospitalier Piti\u00e9\u2013Salp\u00eatri\u00e8re French National Referral Center for Systemic Lupus Erythematosus Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders Service de M\u00e9decine Interne 2 Institut E3M, Inserm UMRS Centre d\u2019Immunologie et des Maladies Infectieuses (CIMI\u2010Paris)  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1100359"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60128-8"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211663"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203863"},{"key":"e_1_2_7_6_1","first-page":"1785","article-title":"Anti\u2010dsDNA antibody testing by Farr and ELISA techniques is not equivalent","volume":"33","author":"Neogi T","year":"2006","journal-title":"J Rheumatol"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10558"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2004.07.002"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115843"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203310371161"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.64"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2011.0071"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2011.01.009"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket403"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2013.02.013"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197907053010102"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6176024"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780250407"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021553"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0337679100"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38628"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.48.10.861"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1191\/096120300674499064"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.033753"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24803"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex220"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208562"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39962"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1089\/107999099313901"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22044"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.4061\/2009\/374312"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2887"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20798"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21031"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309105529"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1641"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/2211068215589580"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161451"},{"key":"e_1_2_7_39_1","first-page":"267","article-title":"Early intrathecal synthesis of interferon in herpes encephalitis","volume":"31","author":"Lebon P","year":"1979","journal-title":"Biomedicine"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(88)90125-6"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20068"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400928"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350606"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051135"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00443.x"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/251543a0"},{"key":"e_1_2_7_48_1","first-page":"37","article-title":"Production of human type I interferon by lymphocytes in contact with cells infected by herpes virus and fixed with glutaraldehyde","volume":"290","author":"Lebon P","year":"1980","journal-title":"C R Seances Acad Sci D"},{"key":"e_1_2_7_49_1","first-page":"509","article-title":"FC\u03b3RII (CD32)\u2010dependent induction of interferon\u2010\u03b1 by serum from patients with lupus erythematosus","volume":"10","author":"Batteux F","year":"1999","journal-title":"Eur Cytokine Netw"},{"key":"e_1_2_7_50_1","first-page":"1135","article-title":"Herpes encephalitis in adults and interferon","volume":"10","author":"Vezinet F","year":"1981","journal-title":"Nouv Presse Med"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209519"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.2307\/2531595"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70258-8"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-016-0359-1"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)90529-1"},{"key":"e_1_2_7_56_1","first-page":"2239","article-title":"Serologically active clinically quiescent systemic lupus erythematosus\u2013predictors of clinical flares","volume":"21","author":"Walz LeBlanc BA","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.093146"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30187"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.111467"}],"container-title":["Arthritis &amp; Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.40792","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.40792","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/art.40792","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.40792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T12:27:33Z","timestamp":1759926453000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/art.40792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1002\/art.40792"],"URL":"https:\/\/doi.org\/10.1002\/art.40792","archive":["Portico"],"relation":{},"ISSN":["2326-5191","2326-5205"],"issn-type":[{"value":"2326-5191","type":"print"},{"value":"2326-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,25]]},"assertion":[{"value":"2017-12-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}